China Molecular Diagnostics Market Outlook


By the end of 2022, China Molecular diagnostics is projected that it will perform around 300 million molecular diagnostic tests. China molecular diagnostics can be categorized into three segments i.e. Oncology Test, Infectious disease Test and Genetic disease Test. Moreover, these segments were further categorized into their respective sub segments i.e. In Oncology test, Breast Cancer Test, Colorectal Cancer Test and Prostate Cancer Test. Infectious Disease Test is segmented into Virology and HPV. Genetic Test is further segmented into Blood Screening and HLA.

Read »
Created by renubresearch 3 years 41 weeks ago – Made popular 3 years 40 weeks ago
Category: Health   Tags:

Reliable. Secure. Since 2012. Sign up to get a trading fee discount!